ReviewInternational journal of molecular sciences2021

Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19.

Barbara Malinowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.